BioTech 365

JULY 8, 2021

AVEO Oncology to Host Key Opinion Leader Webinar on FOTIVDA® (tivozanib) for Relapsed or Refractory Renal Cell Carcinoma AVEO Oncology to Host Key Opinion Leader Webinar on FOTIVDA® (tivozanib) for Relapsed or Refractory Renal Cell Carcinoma Webinar on Friday, July … Continue reading →

52

52

XTalks

JUNE 1, 2022

Edward Ashton, PhD, VP, Oncology Imaging, Philips BioTel Research, about the latest advancements in oncology imaging powered by the integration of new technologies like artificial intelligence. Watch the video here: Xtalks Voices with Imaging Oncology expert Dr. Edward Ashton from Phillips BioTel Research.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Research 97

Drug Channels

NOVEMBER 14, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. (Or,

Drugs 77

Drugs Pharmacy Marketing 77

Drug Discovery World

APRIL 3, 2023

Hosted by DDW and supported by Tecan, “How next-generation sequencing is informing oncology drug discovery” will be free to attend on April 24 at 7AM PST / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn about the biggest challenges and opportunities facing the NGS oncology space. You will hear from Darrell Green, a lecturer in (..)

RNA 52

RNA Drugs Genome Genomics 52

Drug Discovery World

APRIL 18, 2023

Join this free webinar to learn about the biggest challenges and opportunities facing the next-generation sequencing (NGS) oncology space. The post Register now to learn how NGS is informing oncology drug discovery appeared first on Drug Discovery World (DDW). Register now.

RNA 52

RNA Drugs Genome Genomics 52

Worldwide Clinical Trials

JUNE 15, 2022

At the end of May, we hosted a webinar titled “ Changing Times, Changing Therapies: Keeping Up with Advancements in Cell and Gene Therapies ” to provide a quick update on the latest advancements and ongoing in development of these advanced therapeutics. We’re noticing that around half of clinical holds are for oncology programs.

Gene Therapy 130

Gene Therapy Gene Clinical Trials Clinical Trials 130

pharmaphorum

NOVEMBER 17, 2022

Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology. This webinar will also explore: How the changing nature of communications technology and modalities are changing the MSL’s role.

Production 115

Production Development Research 115

Drug Discovery World

APRIL 4, 2023

The post Next-generation sequencing and oncology drug discovery appeared first on Drug Discovery World (DDW). Register now.

Drugs 52

Drugs RNA Genome Genomics 52

Drug Discovery World

MAY 5, 2023

In this webinar, you will hear from immunologist Dr Frédéric Triebel, CSO and CMO of Immutep, two experts from DeciBio: Dr Carl Schoellhammer, Principal, and Dr Joe Daccache, Senior Life Science Expert, Veronique Baron, Scientific Applications Manager, Marketing at BPS Bioscience, and Dr Hengshuo Liu, Technical Sales Specialist at ACROBiosystems.

Protein 52

Protein Life Science Sales Production 52

Drug Discovery World

APRIL 28, 2023

In this webinar, you will hear from immunologist Dr Frédéric Triebel, CSO and CMO of Immutep, two experts from DeciBio: Dr Carl Schoellhammer, Principal, and Dr Joe Daccache, Senior Life Science Expert, Veronique Baron, Scientific Applications Manager, Marketing at BPS Bioscience, and Dr Hengshuo Liu, Technical Sales Specialist at ACROBiosystems.

Protein 52

Protein Life Science Sales Production 52

XTalks

DECEMBER 29, 2023

XTALKS WEBINAR: Strategic Implications of Oncology Clinical Trial Design in Early-Phase Studies Live and On-Demand: Friday, February 16, 2024, at 11am EST (4pm GMT/UK) Register for this free webinar to delve into how strategic oncology clinical trial design shapes success in early oncology studies using novel approaches.

Clinical Trials 119

Clinical Trials Clinical Trials FDA Approval Trials 119

Drug Channels

DECEMBER 13, 2023

This week, I’m rerunning some popular posts while I prepare for Fiday's Drug Channels Outlook 2024 live video webinar. For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs.

Manufacturing 82

Manufacturing Pharmacy Drugs Production 82

Drug Discovery World

APRIL 21, 2023

Cell therapies are an important class of therapy in immuno-oncology. Dr Frédéric Triebel Dr Carl Schoellhammer Dr Hengshuo Liu Dr Joe Daccache The post Webinar on the future opportunities for cancer immunotherapy appeared first on Drug Discovery World (DDW). Register now.

Life Science 52

Life Science Sales Protein Production 52

pharmaphorum

NOVEMBER 9, 2021

Once widely acknowledged as so special that only scientists and clinical specialists need to apply, oncology has become exponentially more clinically targeted and sophisticated over the last decade. The success of branding in immuno-oncology. Michael Gaschler, PhD , Senior Consultant, Oncology, Cerner Enviza.

Branding 98

Branding Scientist Marketing Containment 98

XTalks

OCTOBER 7, 2022

The US Food and Drug Administration (FDA) has granted approval to Taiho Oncology, Inc. Taiho Oncology, Inc. Lytgobi was evaluated under the FDA’s Real Time Oncology Review (RTOR) pilot and was granted accelerated approval due to its impressive overall response rate and response duration, according to Taiho.

FDA Approval 98

FDA Approval Gene Trials Drugs 98

Drug Discovery World

FEBRUARY 6, 2023

On February 17 at 8am PST / 11am EST / 4pm GMT / 5pm CET, join DDW to enjoy this free webinar, Cell and gene therapy: sustaining growth and maximising opportunities. Join this free webinar , supported by BPS Bioscience and Benchling, to learn about the biggest challenges and opportunities facing the cell and gene therapy sector.

Gene Therapy 52

Gene Therapy Gene Development Manufacturing 52

Drug Discovery World

MAY 5, 2023

To learn more about where the future opportunities in immunotherapy will be found, register for DDW’s free webinar on May 10 – details below. Eterna acquires Exacis’ allogeneic immuno-oncology platform Eterna Therapeutics, a life science company focused on mRNA cell engineering, has acquired Exacis Biotherapeutics’ immuno-oncology platform.

Drugs 52

Drugs Bacteria Life Science Engineer 52

Drug Discovery World

APRIL 21, 2023

Cell therapies are an important class of therapy in immuno-oncology. Hosted by DDW and supported by BPS BioScience and AcroBiosystems, ‘Cancer immunotherapy – where will the future opportunities be?’

Life Science 52

Life Science Sales Protein Production 52

VirTrial

JANUARY 2, 2024

We analyzed web traffic, content downloads, social media engagement, video views, webinar attendance, and other metrics to determine the themes that caught your attention which happen to align with broader industry trends. Our experts discussed opportunities and real uses cases for this technology in two recent webinars.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

XTalks

JANUARY 26, 2024

Key breakthroughs at the forefront include novel approaches to cancer treatment and diagnosis, the integration of artificial intelligence (AI) in oncology and the development of advanced preventive measures and care. The ongoing innovations in CRISPR/Cas9 gene-editing, CAR T-cell therapies and AI in oncology present hope.

Research 118

Research Gene Editing Gene Genetics 118

Drug Discovery World

JANUARY 30, 2023

Register to attend Cell and gene therapy: sustaining growth and maximising opportunities, a free-to-attend DDW webinar, supported by Benchling and BPS Bioscience, on February 17, 2023 at 8am PST / 11am EST / 4pm GMT / 5pm CET. autologous therapies/solid tumours/ indications outside of oncology?)     Register for free here.

Gene Therapy 52

Gene Therapy Gene Development Manufacturing 52

Drug Discovery World

JANUARY 25, 2023

Join this free webinar , hosted by DDW and supported by BPS Bioscience and Benchling, to learn about the biggest challenges and opportunities facing the cell and gene therapy sector. autologous therapies/solid tumours/ indications outside of oncology?)     The webinar will take place on February 17, 2023 4PM GMT. 

Gene Therapy 52

Gene Therapy Gene Development Manufacturing 52

Drug Discovery World

OCTOBER 31, 2022

Collaborative Drug Discovery (CDD) is hosting a webinar in which CDD’s Eric Gifford speaks with two industry experts, Dr Josh Horan and Dr Michael Kappler about their experience working with data at biotech companies. . The live webinar will take place on December 1, 2022 at 8AM (PT), 11AM (ET) or 4PM (GMT). .

Drugs 52

Drugs Medicine Research 52

XTalks

JULY 21, 2023

These members now have access to the advanced Iris platform, offering specialized mental health care tailored for oncology patients, 24×7 symptom management and essential nutritional support. All of these services are available at no cost through participating health plans.

Nurses 98

Nurses Doctors Doctor Clinical Trials 98

Drug Discovery World

FEBRUARY 13, 2023

Join this free webinar to learn about the biggest challenges and opportunities facing the cell and gene therapy sector. autologous therapies/solid tumours/ indications outside of oncology?)     Register for free here. The post Webinar: Opportunities for CGT in drug development appeared first on Drug Discovery World (DDW).

Gene Therapy 52

Gene Therapy Development Drugs Gene 52

XTalks

JANUARY 16, 2024

RELATED XTALKS WEBINAR: Case Study: EEG Digital Biomarkers in Neuropsychiatric Clinical Studies Live and On-Demand: Thursday, February 15, 2024, at 12pm EST (9am PST) Register for this free webinar to learn how digital biomarkers have the potential to transform neuropsychiatry, enabling personalized treatment.

Development 122

Development Drugs Clinical Trials Clinical Trials 122

XTalks

FEBRUARY 9, 2023

Leading clinical trials technology platform provider Medable announced a new partnership with Nova Scotia Health Innovation Hub for a two-year pilot study to improve oncology trial access for patients in rural Nova Scotia through Medable’s decentralized clinical trial (DCT) platform. Nova Scotia is Canada’s second smallest province by area.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

XTalks

FEBRUARY 14, 2024

Advancements in Pediatric Oncology In recent years, pediatric oncology has witnessed remarkable progress and the treatment options to combat childhood cancer have offered new hope to the affected families.

Hormones 52

Hormones Development Genetics Life Science 52

Pharma Marketing Network

DECEMBER 29, 2020

As telehealth appointments replaced office visits, webinars replaced in-person conferences and digital communication replaced reps in the field, what have we learned about how to create connection within this new paradigm? Ryan Billings , Head, US Oncology Digital Marketing & Customer Experience at GSK. SAVE MY SEAT.

Branding 98

Branding Marketing 98

pharmaphorum

FEBRUARY 24, 2022

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), will be held Wednesday 23rd March at 15:00 GMT / 16:00 CET. The webinar will cover: What new kinds of data is available to commercial researchers. Ed Merivale is therapy relationship manager, oncology at NIHR.

Clinical Research 105

Clinical Research Research Life Science Clinical Trials 105

XTalks

DECEMBER 21, 2023

Fruzaqla is the first novel chemotherapy-free treatment option approved for patients in the US regardless of biomarker status in more than a decade,” said Teresa Bitetti, president of the Global Oncology Business Unit at Takeda, in the company’s press release.

FDA Approval 52

FDA Approval Clinical Trials Clinical Trials DNA 52

Drug Channels

DECEMBER 14, 2023

This week, I’m rerunning some popular posts while I prepare for tomorrow’s Drug Channels Outlook 2024 live video webinar. In case you haven’t noticed, private equity firms have displaced hospitals and health systems as the major acquirers of community oncology practices. Click here to see the original post from October 2023.

Drugs 52

Drugs 52

XTalks

AUGUST 18, 2023

XTALKS WEBINAR: Advances in oncological imaging: Tumour growth rate modelling and radiomics Live and On-Demand: Thursday, October 12, 2023 , at 10am EDT (4pm CEST / EU-Central) Register for this free webinar to learn the basics of tumor growth rate modelling from oncological imaging data, as well as radiomics.

FDA Approval 98

FDA Approval Drugs Antibody Trials 98

XTalks

DECEMBER 4, 2023

Most oncology products approved in the past few decades are known for being highly toxic, non-specific and fraught with severe side effects for cancer patients. But today, with a rise in molecularly targeted therapies, oncology development has shifted to identifying an optimal biologic dose that balances toxicity with efficacy.

Development 111

Development Drugs Clinical Trials Clinical Trials 111

XTalks

SEPTEMBER 25, 2023

Given this high unmet need, we are proud to add Ojjaara to our oncology portfolio and address a significant medical need in the community. We look forward to helping improve outcomes in this difficult-to-treat blood cancer,” said Nina Mojas, Senior Vice President, Oncology Global Product Strategy, GSK, in the company’s press release.

Clinical Trials 59

Clinical Trials Clinical Trials Trials FDA Approval 59

Drug Discovery World

JANUARY 25, 2023

In this free webinar on February 17, 2023 you will hear from CBO/CDO of Adthera Bio, Stuart Curbishley, Chief Executive Officer of Cell & Gene Therapy Catapult, Matthew Durdy, Founder and CEO of Dark Horse Consulting, Anthony Davies, and Scientific Solutions Consultant at Benchling, Brian Fan. Register for free now.

Gene Therapy 52

Gene Therapy Gene Marketing Development 52

XTalks

AUGUST 14, 2023

XTALKS WEBINAR: Cancer Immunotherapy: Exploring Imaging as a Catalyst to Immune Response Prediction Live and On-Demand: Wednesday, September 27, 2023, at 2pm EDT (11am PDT) Register for this free webinar to discover the present and transformative impact of predictive biomarkers on immunotherapy response.

FDA Approval 97

FDA Approval Antibody Immune Response Drugs 97